This narrative review highlights current evidence linking greater body fatness to risk of
various cancers, with focus on evidence from recent large cohort studies and pooled …

Background We aimed to map and describe the current state of Mendelian randomization
(MR) literature on cancer risk and to identify associations supported by robust evidence …

OBJECTIVE COVID-19 has become a major public health problem. There is good evidence
that ACE2 is a receptor for SARS-CoV-2, and high expression of ACE2 may increase …

Background Evidence for the impact of body size and composition on cancer risk is limited.
This mendelian randomisation (MR) study investigates evidence supporting causal …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid
malignancies, which is featured by systematic metabolism. Thus, a better understanding of …

Pancreatic cancer has an incidence that almost matches its mortality. Only a small number of
risk factors and 33 susceptibility loci have been identified. so Moreover, the relative rarity of …

Associations of obesity have been established for at least 11 cancer sites in observational
studies, though some questions remain as to causality, strength of associations, and timing …

Excess body weight has been established as a risk factor for at least twelve cancer sites,
though questions remain as to the timing of associations for adiposity and cancer risk …

Pancreatic cancer (PC), particularly its most common form, pancreatic ductal
adenocarcinoma (PDAC), is relatively rare but highly lethal. Knowledge about PC risk …

Background Observational studies have reported multiple risk factors for pancreatic ductal
adenocarcinoma (PDAC). Some are well established, like tobacco smoking, alcohol …